Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (23) , 22473-22481
- https://doi.org/10.1074/jbc.m500963200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Previous issuesSeminars in Oncology, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- PTEN: tumour suppressor, multifunctional growth regulator and moreHuman Molecular Genetics, 2003
- Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoterJournal of Medical Genetics, 2002
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Genomic organization and promoter characterization of human CXCR4 gene1FEBS Letters, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Human squamous cell lung cancers express increased epidermal growth factor receptors.Journal of Clinical Investigation, 1984